Authors:
Avinash Singh, Amit Patil
Download free PDF
North America Eye Cream Market Size & Share 2026-2035
Report ID: GMI15645
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
North America Eye Cream Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
North America Eye Cream Market Size
The North America eye cream market was valued at USD 1.3 billion in 2025 and is estimated at USD 1.4 billion in 2026. It is projected to reach USD 2.6 billion by 2035, expanding at a CAGR of 7.6% from 2026 to 2035, supported by demand for hydration, age-management, pigmentation, and fatigue-focused products formulated for the eye contour.
North America Eye Cream Market Key Takeaways
Market Leader: Estée Lauder Companies Inc. led with over 17% market share in 2025.
Leading Players: Top 5 players in this market include Estée Lauder Companies Inc., L’Oréal Group, Procter & Gamble, Johnson & Johnson Consumer Health, Beiersdorf AG, which collectively held a market share of 50% in 2025.
Demographic demand is widening the addressable base for preventive and corrective eye-area products. The U.S. population aged 65 and older reached 61.2 million in 2024, equivalent to 18.0% of the population, after growing 13.0% between 2020 and 2024 [1]U.S. Census Bureau, census.gov. This supports recurring demand for products positioned around fine lines, elasticity, dark circles, and under-eye puffiness rather than only occasional cosmetic use.
Digital-device behavior adds a separate demand trigger, especially for de-puffing, brightening, and fatigue-oriented propositions. More than 104 million working-age Americans spend over seven hours a day viewing digital screens, while screen exposure can contribute to digital-eye-strain symptoms [2]American Optometric Association, aoa.org. In a 2023 U.S. consumer survey, nearly seven in ten adults aged 18–44 reported symptoms associated with digital eye strain, and more than half reported spending at least six hours daily on digital devices. These conditions do not establish a direct clinical need for eye cream, but they reinforce consumer interest in products that address the visible consequences associated with tired-looking eyes.
GMI Analyst View
North American growth is becoming less dependent on a single anti-aging consumer cohort. Aging demographics create a durable base for wrinkle- and firmness-led products, while screen-intensive work and digital lifestyles enlarge demand for products that address fatigue, puffiness, and uneven tone. The result is a market in which multi-benefit formulations can improve repeat-purchase potential by serving several routines at once, but only if claims remain credible and the product is tolerable around a sensitive application area.
Competitive advantage will increasingly rest on the ability to translate recognized actives into a clear eye-area use case. Brands that merely add retinol, caffeine, or hyaluronic acid to a broad skincare portfolio may face rapid comparability. Brands that pair ingredient selection with tolerability, clinically relevant substantiation, and channel-specific education are better positioned to defend premium pricing as consumers become more capable of comparing formulas and claims.
Key Drivers
Rising aging and preventive-skincare demand
The aging of the U.S. population supports demand for eye creams positioned around preventive maintenance as well as visible correction. The number of Americans aged 65 and older is projected to reach 95 million by 2060, compared with 49 million in 2016 [3]U.S. Census Bureau, census.gov. Although eye cream demand is not limited to older consumers, the expansion of mature age groups supports longer product-use cycles for formulas targeting fine lines, dryness, loss of firmness, and uneven pigmentation.
Clinical literature provides a clearer foundation for ingredient-led purchasing than broad anti-aging language alone. A 2024 review found evidence that retinoids, hyaluronic acid, caffeine, niacinamide, peptides, and vitamins can improve aspects of periorbital hydration, elasticity, collagen synthesis, pigmentation, or wrinkle appearance [4]International Journal of Women's Dermatology, Hamie et al., 2024, journals.lww.com. For manufacturers, the commercial opportunity lies in matching a specific active to a visible concern and an appropriate skin-tolerance profile, rather than relying on generalized "anti-aging" claims.
High awareness of ingredient efficacy
Ingredient education is reshaping the category from a texture- and prestige-led purchase toward a more comparative formulation decision. Retinol, a vitamin A derivative, is widely used in anti-aging eye products because it stimulates collagen and is associated with reducing the appearance of lines and wrinkles. However, the eye area's sensitivity raises the importance of concentration, delivery system, barrier-supporting ingredients, and consumer instructions.
This dynamic favors brands that can explain why an ingredient is present, how it addresses a specific concern, and why its formulation is suitable for the eye contour. Shiseido's Vital Perfection Uplifting and Firming Advanced Eye Cream, for example, combines RetinolACE and hyaluronic acid with caffeine-containing MicroVitalizer Technology to address signs associated with fatigue and aging. Such formulations establish a higher standard for product differentiation than a single-ingredient message.
Strong e-commerce and direct-to-consumer penetration
Digital commerce improves discovery for niche eye-care formats, particularly products with distinctive claims, clinical positioning, or premium price points. Digital channels accounted for 41% of U.S. beauty and personal-care sales in 2025, while U.S. cosmetics and beauty e-commerce sales were expected to grow 9.8% during the year. The channel enables brands to present ingredient education, before-and-after routines, subscription options, and product comparisons that are difficult to replicate through a limited retail shelf display.
Direct-to-consumer infrastructure is also becoming a competitive capability for established companies. The Estée Lauder Companies announced a partnership with Shopify in October 2025 to build an AI- and data-enabled direct-to-consumer platform, with the first phase expected in the first quarter of 2026. In eye cream, where consumers often need reassurance on sensitivity, efficacy, and product layering, stronger first-party digital experiences can reduce the distance between product education and purchase.
Key Restraints
Market saturation and intense competition
The category has low barriers to conceptual entry because many brands can formulate around recognizable actives such as caffeine, retinol, niacinamide, peptides, and hyaluronic acid. The harder challenge is differentiating performance in a small, high-scrutiny application area. Product launches can fragment demand, increase promotional activity, and reduce the ability of established brands to rely on heritage alone.
Regulatory obligations compound this pressure. The Modernization of Cosmetics Regulation Act expanded FDA authority over cosmetics through requirements that include facility registration, product and ingredient listing, serious adverse-event reporting, safety substantiation records, and forthcoming good manufacturing practice regulations. Compliance may strengthen trust over time, but it also requires smaller and emerging suppliers to maintain more disciplined quality and documentation systems.
Price sensitivity in mass and mid-range segments
Consumers may pay for products with credible efficacy or sensory differentiation, but the category contains highly visible price comparisons across drugstores, department stores, specialty beauty retail, and online marketplaces. Olay's Ultimate Eyes product, positioned around dark circles, wrinkles, and puffiness, is listed at USD 39.99 and combines peptides and vitamins in a three-in-one format. Such offers create a reference point for mid-priced consumers assessing whether prestige products provide sufficiently distinct benefits to justify a premium.
Price pressure is particularly relevant where a product's claims appear substitutable with facial moisturizers, serums, or lower-priced eye products. Brands therefore need to show why an eye-specific formula offers a relevant advantage, whether through ophthalmologist testing, targeted delivery, sensory suitability, packaging precision, or an active system that cannot be easily compared on an ingredient list alone.
GMI Analyst View
Sustainable positioning in North America will require more than premium packaging or an extensive active-ingredient list. As consumers compare product claims across price tiers, the commercially defensible proposition is one that connects a recognized ingredient with a differentiated delivery method, tolerability profile, and observable concern. This makes clinical substantiation, precise education, and repeat-use experience more important than broad positioning language.
Saturation should not be interpreted as a uniform constraint across every price point. It is most damaging where products are interchangeable and promotions become the main conversion lever. Brands that establish authority in sensitive-eye care, dermatologist-led routines, or technically differentiated retinal and retinol delivery can reduce direct price comparability, although their ability to sustain that advantage depends on meeting the quality and compliance expectations associated with cosmetic regulation.
North America Eye Cream Market Segment Analysis
By Type
Moisturising eye cream is the largest type segment, accounting for 29.7% of the market in 2025. Its leading position reflects the broad relevance of hydration to dry, mature, and sensitive eye-area skin, as well as its compatibility with preventive routines. Hyaluronic acid is particularly important to this segment because clinical evidence indicates that low-molecular-weight topical hyaluronic acid can improve hydration, elasticity, and roughness.
Anti-aging eye cream holds a 24.5% share and remains the segment most directly connected to population aging and preventive skincare. Its growth is supported by retinoid, peptide, and vitamin-led formulations, although efficacy must be balanced against irritation risk near the eye contour. Forming eye cream accounts for 14.6%, while brightening eye cream represents 18.3%, supported by demand for products addressing dark circles and uneven tone. Caffeine's documented potential to reduce periorbital pigmentation supports the logic of brightening and fatigue-oriented formulations.
Anti-allergy eye cream represents 10.0% of market revenue. This segment is shaped by the need for formulations suitable for allergy-prone and highly sensitive users. La Roche-Posay's Toleriane Dermallergo Eye Cream is positioned for sensitive to ultra-sensitive eye contour skin and uses probiotic-derived fractions and neurosensine [5]La Roche-Posay UK, laroche-posay.co.uk. De-puffing eye cream accounts for approximately 2.9%; its smaller base reflects a more concentrated use case, but screen-related fatigue and caffeine-led product messaging provide scope for category development.
By Ingredient
Vitamin E leads the ingredient segment with a 28.4% share in 2025 and a projected CAGR of 7.8%. Its role in antioxidant-oriented and moisturising formulations supports broad compatibility across routine types. Other ingredients, including hyaluronic acid, account for 23.0% and are projected to expand at a 6.9% CAGR, reflecting their importance in hydration, elasticity, and barrier-oriented formulations.
Vitamin A represents 21.4% of the market and is projected to grow at 7.5%, while niacinamide holds 17.5% and is projected to expand at 7.1%. Retinol accounts for 9.7% and is forecast to grow at 6.3%. The lower share of retinol relative to broader vitamin A reflects formulation constraints in the eye area: retinoid efficacy is commercially valuable, but brands must manage sensitivity, stability, and consumer-use guidance.
Encapsulation is one route to resolving that constraint. Research on retinol-loaded cationic copolymeric nanoparticles found that the particles protected retinol from oxidation for at least eight weeks and enabled controlled release over 18 hours [6]MDPI Cosmetics, mdpi.com. Murad applies pharmaceutical-derived encapsulated retinal technology in its Retinal ReSculpt Eye Lift Treatment, positioning the system around stability and targeted delivery. This type of formulation innovation can shift competition from ingredient recognition toward delivery-system credibility.
By Skin Type
The Others segment, including all-skin and sensitive-skin products, leads with a 49% share in 2025. This reflects the commercial appeal of products that minimize exclusion from the outset, particularly in an area where irritation, dryness, and allergy concerns can discourage experimentation. Sensitive-skin compatibility is not simply a niche claim; it can determine whether consumers continue using an active-based product long enough to assess its effects.
Dry-skin formulations retain a meaningful role because the periorbital area is prone to visible dehydration and texture changes. Oily-skin products are more selective, often emphasizing lightweight textures, rapid absorption, and avoidance of heavy occlusive finishes. The most scalable products may combine broad-skin-type compatibility with a clear concern-led proposition rather than relying on an overly narrow skin classification.
By Price
Low-priced products compete primarily on accessibility, familiar ingredients, and mass-retail availability. Medium-priced products occupy the category's most contested range because they must offer a noticeable step-up in formula, sensorial performance, or brand trust without losing price-sensitive consumers to mass alternatives. High-priced products depend more heavily on clinical positioning, luxury heritage, advanced delivery systems, and professional endorsement.
Shiseido's Vital Perfection Advanced Eye Cream, listed at USD 95, illustrates how prestige products use specialized retinol technology, caffeine-containing systems, and rapid visible-result claims to justify premium pricing. The premium opportunity remains viable, but only where the formulation story is sufficiently differentiated from lower-priced retinol, peptide, and hyaluronic-acid alternatives.
By Application
Professional application accounts for 55% of the market in 2025, compared with 45% for personal application. Professional use is supported by dermatologists, aestheticians, and high-end skincare clinics incorporating advanced eye creams into treatments targeting wrinkles, dark circles, and puffiness. This channel can serve as a credibility mechanism for brands, particularly where consumers seek advice before using retinoids or other actives close to the eye.
Personal application remains essential to volume growth because eye cream is increasingly integrated into daily skincare routines. The most successful professional-to-personal crossover products can use clinic or dermatologist association to build trust while maintaining accessible instructions and replenishment options for at-home use.
By Sales Channel
Online sales include e-commerce marketplaces and company websites, while offline sales include hypermarkets, supermarkets, department stores, and other retail formats. Online channels are especially relevant to ingredient-led eye creams because consumers can compare formulations, read reviews, evaluate prices, and access longer educational content before purchase. Company websites also provide control over product storytelling, routine guidance, and customer data.
Offline retail remains important for discovery, immediate access, gifting, and prestige consultation. Department stores and specialty beauty environments can support premium products through demonstrations and sales assistance, whereas mass retailers remain essential for broad access to moisturising and multi-benefit formats. The market's channel structure therefore favors brands capable of maintaining consistent claims and pricing logic across owned, marketplace, and physical retail environments.
GMI Analyst View
The strongest segment-level growth vectors lie at the intersection of broad demand and credible technical differentiation. Moisturising products offer the largest base because hydration is relevant across age groups and skin types, but their defensibility improves when they incorporate barrier-supporting or sensitive-eye positioning. Anti-aging products can deliver higher value per unit when retinoid or peptide systems are paired with evidence-based tolerability rather than being marketed as generic corrective treatments.
Ingredient leadership will not necessarily translate into pricing power. Vitamin E and hyaluronic acid support accessible, broadly compatible propositions, whereas retinal or encapsulated retinol systems can create a more differentiated premium proposition if the delivery technology is explained clearly. Manufacturers should therefore treat ingredient selection and delivery design as linked decisions: recognized actives drive discovery, but product-specific proof, eye-area suitability, and professional validation determine whether consumers stay with the brand.
North America Eye Cream Market Regional Analysis
U.S.
The U.S. generates USD 0.80 billion in 2025 and accounts for 61.2% of the North America eye cream market. Its projected 8.2% CAGR exceeds the regional average, supported by a large mature consumer base, high digital-commerce participation, substantial professional skincare infrastructure, and rapid adoption of ingredient-led products.
The country also has the deepest competitive mix across prestige, masstige, clinical, dermatological, and mass-market eye cream brands. The Estée Lauder Companies reported USD 6.96 billion in fiscal 2025 skincare revenue across its global portfolio, which includes Estée Lauder, Clinique, La Mer, Dr.Jart+, and the DECIEM family of brands [7]The Estée Lauder Companies, elcompanies.com. This breadth enables large companies to address multiple price points and consumer needs, although it also raises the risk of internal brand overlap.
Product launches continue to broaden the market's active-ingredient vocabulary. NIVEA MEN introduced its Age Defense face-care line in the U.S. in February 2025 through Amazon, Walmart, and Target, using Thiamidol and hyaluronic acid to address visible signs of aging [8]PR Newswire - NIVEA MEN Age Defense, prnewswire.com. While the range is not limited to eye cream, it demonstrates the expansion of active-led anti-aging messaging into broad mass-market facial care and reinforces competitive pressure on entry- and mid-tier eye cream products.
Canada
Canada represents USD 0.50 billion in 2025, or 38.8% of the North America market. The market is smaller than the U.S. but offers a distinct regulatory and consumer environment, particularly for sensitive-skin, dermatologist-tested, and cruelty-conscious product positioning.
Canada's animal-testing ban on cosmetics took effect on December 22, 2023. The rules prohibit the sale of cosmetics unless their safety can be established without reliance on prohibited animal-test data, subject to defined provisions. This adds practical importance to product-development documentation and claims governance for brands selling across both North American markets.
Sensitive-skin and fragrance-free positioning may have particular relevance in Canada. NIVEA Canada's Q10 Power Anti-Wrinkle + Fragrance Free moisturizer is marketed for sensitive skin and combines Q10 with creatine in a dermatologically tested format. Although not an eye-specific product, this type of product positioning indicates the broader skincare proposition that eye cream manufacturers can adapt for Canadian consumers who prioritize compatibility and transparent formulation claims.
GMI Analyst View
The U.S. and Canada should be treated as connected but not identical commercialization environments. The U.S. offers the larger scale opportunity and faster growth, making it the priority market for channel experimentation, direct-to-consumer investment, and premium active-led launches. Its scale also intensifies comparison across prestige, professional, and mass brands, so brand differentiation must be visible at the point of digital discovery and retail purchase.
Canada requires a more deliberate trust strategy. Regulatory attention to animal-testing practices, combined with the relevance of fragrance-free and sensitive-skin positioning, can make formulation transparency and substantiation more commercially important than broad aspirational messaging. A unified North America portfolio can create operational efficiency, but successful brands will adapt product claims, retailer communication, and compliance discipline to the differing conditions of each country.
North America Eye Cream Market Share & Competitive Landscape
The North America eye cream market is moderately consolidated. The Estée Lauder Companies Inc. leads with an estimated share of approximately 17%, while the top five companies - The Estée Lauder Companies Inc., L'Oréal Group, Shiseido Company Limited, Unilever PLC, and Beiersdorf AG - collectively account for approximately 50% of regional revenue.
Competition is shaped by portfolio breadth, formulation credibility, access to professional channels, and digital-commerce capability. The Estée Lauder Companies combines prestige brands with DECIEM's science-oriented brands, providing reach across luxury, dermatologist-adjacent, and ingredient-conscious consumer segments. L'Oréal competes through dermatological and prestige brands, including La Roche-Posay, Lancôme, and Vichy. La Roche-Posay's U.S. eye-care portfolio includes ophthalmologist-tested formulas such as Redermic R Retinol Eye Cream and Toleriane Dermallergo Eye Cream, addressing both anti-aging and allergy-prone sensitive-eye needs [9]La Roche-Posay US, laroche-posay.us.
Beiersdorf's North American strategy is supported by dermocosmetic and mass-market reach. The company reported 3.8% organic sales growth in North America in fiscal 2025, with Eucerin, Aquaphor, and Chantecaille among its growth drivers. Shiseido competes in premium eye care through specialized retinol and fatigue-focused formulations, while Unilever's Murad brand supports a clinically positioned approach through encapsulated retinal technology. Unilever's Beauty & Wellbeing business reported 4.1% underlying sales growth in the first quarter of 2025, indicating continued momentum in its beauty portfolio.
The competitive landscape also includes Alastin Skincare, Amorepacific Corporation, Coty Inc., Deciem, Johnson & Johnson Consumer Health, LVMH Moët Hennessy Louis Vuitton, Murad LLC, Proactiv Company, Procter & Gamble, Supergoop! LLC, and the major companies identified above. Their routes to differentiation vary from dermatologist-led and clinical positioning to prestige branding, mass-market accessibility, digital discovery, and specialized active technologies.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Question(FAQ) :
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →